3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
NET
1
Endocrine
1
CNS
1
Conditions
Prostatic Neoplasms
3
Neuroendocrine Tumors
2
Lymphoma
2
Uterine Cervical Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Osteosarcoma
1
Neurodegenerative Diseases
1
Myocarditis
1
Hematologic Neoplasms
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Brain Neoplasms
1
Anus Neoplasms
1
Adenocarcinoma
1
Interventions
Surveys and Questionnaires
15
Radiosurgery
14
Magnetic Resonance Imaging
11
Magnetic Resonance Spectroscopy
10
Neuropsychological Tests
8
Radiotherapy
7
Radiation
4
Blood Specimen Collection
4
Patient Reported Outcome Measures
3
sacituzumab govitecan
2
Trastuzumab
2
Surgical Procedures, Operative
2
Quality of Life
2
Physical Examination
2
Phlebotomy
2
Perfusion Magnetic Resonance Imaging
2
Lead
2
Lapatinib
2
Interviews as Topic
2
Immunotherapy
2
Drug Therapy
2
Data Collection
2
Brain Mapping
2
Bevacizumab
2
Amplified Fragment Length Polymorphism Analysis
2
Aminolevulinic Acid
2
trastuzumab deruxtecan
1
pembrolizumab
1
osimertinib
1
lorlatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Brain Neoplasms
×
Positron-Emission Tomography
×
Clear all
NCT06211803
2024-01-18
JPETClinic
Jagiellonian University
Completed
10 enrolled